Ocular Therapeutix: Redefining the Management of nAMD: The Impact of Durability and Sustained Disease Control

Ocular Therapeutix: Redefining the Management of nAMD: The Impact of Durability and Sustained Disease Control

Location: Schubert 1
Date & Time: Friday, 2nd October, 09:45 – 10:45 CEST
Chairperson(s): A. Khanani (USA)

Speakers:

Presentations:

P. Kaiser (USA)

09:45 Science Behind the Therapy

A. Khanani (USA)

09:55 SOL-1: Trial Overview & Primary Endpoint

P. Schlottmann (Argetina)

10:05 SOL-1: Additional Outcomes

D. Dhoot (USA)

10:20 SOL-1: Clinical Evidence

A. Tufail (UK)

10:30 Key Insights

Back to Main Programme

www.euretina.org is the only official website of the European Society of Retina Specialists.

Please be wary of websites, emails from third-party agencies using similar names, addresses or branding and purporting to represent Euretina.

This includes websites or companies offering Congress registration, hotel accommodation or travel services while claiming to be affiliated with Euretina.

Should you use any website other than www.euretina.org, or book accommodation through an unauthorised third-party site, you may be charged significantly more than the official registration fee, your hotel booking may not be valid, and you may not be registered for the event at all.

If you have any questions in relation to registration or accommodation for the Congress, these should only be directed to [email protected].

Ocular Therapeutix: Redefining the Management of nAMD: The Impact of Durability and Sustained Disease Control

Beware of fraudulent websites, emails and hotel booking offers